Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, February 11, 2025

Innovative 3D blood-brain barrier model enhances understanding of neuroinflammation

 Now our non-existent stroke leadership can direct our researchers to solve and prevent neuroinflammation post stroke. But since there is NO leadership in stroke, NOTHING WILL OCCUR! You're screwed along with all the 10 million yearly stroke survivors now and into perpetuity.

Innovative 3D blood-brain barrier model enhances understanding of neuroinflammation

A 3D model accurately mimicking the Blood-Brain Barrier (BBB) in a laboratory environment has been successfully developed by research teams led by Professor Jinah Jang from the Departments of Mechanical Engineering, Life Sciences, IT Convergence Engineering, and the Graduate School of Convergence at POSTECH, and Professor Sun Ha Paek from the Department of Neurosurgery at Seoul National University Hospital. This study was recently published in Biomaterials Research, an international academic journal on materials science.

Neurodegenerative diseases, including Alzheimer's, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), result from the progressive decline of brain and nervous system functions, primarily due to aging. Chronic neuroinflammation, a key driver of these disorders, arises from the intricate interactions between cerebral blood vessels and neural cells, where the BBB plays a pivotal regulatory role. However, existing BBB models have been unable to replicate the complex three-dimensional 3D structure of cerebral blood vessels, posing significant challenges for research and drug development.

To address these limitations, the research team developed a cerebrovascular-specific bioink using "decellularized extracellular matrix" (CBVdECM), derived from porcine brain and blood vessels. Additionally, the team applied 3D bioprinting technology to construct a tubular vascular model that precisely replicates the anatomical structure and function of the human BBB.

A key feature of this model is the spontaneous formation of a dual-layered structure without external stimuli. When "HBMEC (human brain microvascular endothelial cells)" and "HBVP (human brain vascular pericytes)" were incorporated into the CBVdECM bioink and printed, the endothelial cells self-assembled into the inner vascular wall, while pericytes formed a surrounding layer. This resulted in the creation of a dual-layered structure that closely resembles the architecture of actual blood vessels.

Further, the research team successfully replicated the arrangement and organization process of "tight junction proteins," a component typically absent in conventional 2D models. Additionally, BBB permeability and inflammatory responses were observed following exposure to inflammation-inducing substances (TNF-α and IL-1β). This approach enabled the precise modeling of neuroinflammatory mechanisms, yielding critical insights into the role of BBB dysfunction and inflammation in the pathophysiology of neurodegenerative diseases.

Professor Sun Ha Paek of Seoul National University Hospital commented, "This study provides a crucial platform for investigating the pathological mechanisms of neuroinflammation and developing novel therapeutic strategies."

We aim to integrate additional cell types, such as glial cells, neurons, and immune cells, to refine methods for quantifying inflammatory responses and permeability, while also expanding to patient-specific disease models."

Professor Jinah Jang of POSTECH 

This research was supported by Ministry of Trade, Industry & Energy and the Korea Planning & Evaluation Institute of Industrial Technology's Industrial Technology Alchemist Project, as well as the National Research Foundation of Korea's University-Focused Research Institute Support Program.

Source:
Journal reference:

Han, H., et al. (2024). Cerebrovascular-Specific Extracellular Matrix Bioink Promotes Blood–Brain Barrier Properties. Biomaterials Research. doi.org/10.34133/bmr.0115.

No comments:

Post a Comment